Copy number variations of cytochrome P450 genes in Kinh Vietnamese

[1] Vijzelaar R, Botton MR, Stolk L, Martis S, Desnick RJ, Scott SA. Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification. Pharmacogenomics. 2018; 19:761–70. VijzelaarR BottonMR StolkL MartisS DesnickRJ ScottSA Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification Pharmacogenomics 2018 19 761 70 Search in Google Scholar

[2] Martis S, Mei H, Vijzelaar R, Edelmann L, Desnick RJ, Scott SA. Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation. Pharmacogenomics. 2013; 13:558–66. MartisS MeiH VijzelaarR EdelmannL DesnickRJ ScottSA Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation Pharmacogenomics 2013 13 558 66 Search in Google Scholar

[3] Gaedigk A, Twist GP, Leeder JS. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR. Pharmacogenomics. 2012; 13:91–111. GaedigkA TwistGP LeederJS CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR Pharmacogenomics 2012 13 91 111 Search in Google Scholar

[4] Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, Rodríguez-Antona C. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med. 2018; 20:622–9. SantosM NiemiM HiratsukaM KumondaiM Ingelman-SundbergM LauschkeVM Rodríguez-AntonaC Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics Genet Med 2018 20 622 9 Search in Google Scholar

[5] Tremmel R, Klein K, Battke F, Fehr S, Winter S, Scheurenbrand T, et al. Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression. Hum Genet. 2020; 139:137–49. TremmelR KleinK BattkeF FehrS WinterS ScheurenbrandT Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression Hum Genet 2020 139 137 49 Search in Google Scholar

[6] Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. STrengthening the reporting of OBservational studies in epidemiology – Molecular epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Clin Invest. 2012; 42:1–16. GalloV EggerM McCormackV FarmerPB IoannidisJP Kirsch-VoldersM STrengthening the reporting of OBservational studies in epidemiology – Molecular epidemiology (STROBE-ME): an extension of the STROBE statement Eur J Clin Invest 2012 42 1 16 Search in Google Scholar

[7] Nguyen HH, Ma TTH, Vu NP, Bach QTN, Vu TH, Nguyen TD, Nong HV. Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population. Medicine (Baltimore). 2019; 98:e15891. doi: 10.1097/MD.0000000000015891 NguyenHH MaTTH VuNP BachQTN VuTH NguyenTD NongHV Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population Medicine (Baltimore) 2019 98 e15891 10.1097/MD.0000000000015891 Open DOISearch in Google Scholar

[8] Ahani A, Akbari MT, Saliminejad K, Behnam B, Akhondi MM, Vosoogh P, et al. Screening for large rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex ligation-dependent probe amplification. Mol Vis. 2013; 19: 454–62. AhaniA AkbariMT SaliminejadK BehnamB AkhondiMM VosooghP Screening for large rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex ligation-dependent probe amplification Mol Vis 2013 19 454 62 Search in Google Scholar

[9] Oscarson M, McLellan RA, Gullstén H, Yue QY, Lang MA, Bernal ML, et al. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett. 1999; 448:105–10. OscarsonM McLellanRA GullsténH YueQY LangMA BernalML Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population FEBS Lett 1999 448 105 10 Search in Google Scholar

[10] Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, et al. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics. 2001; 11:317–23. KwonJT NakajimaM ChaiS YomYK KimHK YamazakiH Nicotine metabolism and CYP2A6 allele frequencies in Koreans Pharmacogenetics 2001 11 317 23 Search in Google Scholar

[11] Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther. 2001; 69:72–8. NakajimaM KwonJT TanakaN ZentaT YamamotoY YamamotoH Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans Clin Pharmacol Ther 2001 69 72 8 Search in Google Scholar

[12] Ramírez B, Niño-Orrego MJ, Cárdenas D, Ariza KE, Quintero K, Contreras Bravo NC, et al. Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population. BMC Med Genomics. 2019; 12:110. doi: 10.1186/s12920-019-0556-x RamírezB Niño-OrregoMJ CárdenasD ArizaKE QuinteroK Contreras BravoNC Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population BMC Med Genomics 2019 12 110 10.1186/s12920-019-0556-x Open DOISearch in Google Scholar

[13] Guzey C, Spigset O. Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol. 2006; 26:211–2. GuzeyC SpigsetO Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers J Clin Psychopharmacol 2006 26 211 2 Search in Google Scholar

[14] Varsaldi F, Miglio G, Scordo MG, Dahl ML, Villa LM, Biolcati A, Lombardi G. Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. Eur J Clin Pharmacol. 2006; 62:721–6. VarsaldiF MiglioG ScordoMG DahlML VillaLM BiolcatiA LombardiG Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients Eur J Clin Pharmacol 2006 62 721 6 Search in Google Scholar

[15] Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138:103–41. ZangerUM SchwabM Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation Pharmacol Ther 2013 138 103 41 Search in Google Scholar

[16] Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nat Genet. 2006; 38:75–81. ConradDF AndrewsTD CarterNP HurlesME PritchardJK A high-resolution survey of deletion polymorphism in the human genome Nat Genet 2006 38 75 81 Search in Google Scholar

[17] Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, Ingelman-Sundberg M. Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet. 2010; 127:1–17. Rodriguez-AntonaC GomezA KarlgrenM SimSC Ingelman-SundbergM Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment Hum Genet 2010 127 1 17 Search in Google Scholar

[18] Kaida Y, Inui N, Suda T, Nakamura H, Watanabe H, Chida K. The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer. Clin Pharmacol Ther. 2008; 83:589–94. KaidaY InuiN SudaT NakamuraH WatanabeH ChidaK The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer Clin Pharmacol Ther 2008 83 589 94 Search in Google Scholar

[19] Wang H, Bian T, Liu D, Jin T, Chen Y, Lin A, Chen C. Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes. Pharmacogenomics. 2011; 12:481–92. WangH BianT LiuD JinT ChenY LinA ChenC Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes Pharmacogenomics 2011 12 481 92 Search in Google Scholar

[20] Botton MR, Lu X, Zhao G, Repnikova E, Seki Y, Gaedigk A, et al. Structural variation at the CYP2C locus: characterization of deletion and duplication alleles. Hum Mutat. 2019; 40:e37–51. BottonMR LuX ZhaoG RepnikovaE SekiY GaedigkA Structural variation at the CYP2C locus: characterization of deletion and duplication alleles Hum Mutat 2019 40 e37 51 Search in Google Scholar